Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand

About this item

Title

Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand

Content partner

University of Otago

Collection

Otago University Research Archive

Description

Background and objective: In Aotearoa New Zealand (NZ) widespread transition to budesonide/formoterol maintenance and/or reliever regimens in clinical practice is temporally associated with reduced rates of asthma hospitalization. It is unknown whether this association is observed in Māori, the indigenous population of NZ, who experience a disproportionate burden from asthma. We investigated patterns in asthma medication use and hospital admissions in Māori in NZ.

Format

Research paper

Research format

Scholarly text / Journal article

Thesis level

Article

Date created

2024-12-11

Creator

Eathorne, Allie / Noble, Jonathan / Hatter, Lee / Hills, Tom / Te Paa, Selwyn / Harwood, Matire / Weatherall, Mark / Beasley, Richard

URL

https://hdl.handle.net/10523/44193

Related subjects

New Zealand / Māori / indigenous / asthma / dispensing / inequities / ICS/formoterol

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.